TMED7-TICAM2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 5.289400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.423200E-01
Normal-vs-Stage2
4.968600E-01
Normal-vs-Stage3
7.096800E-01
Normal-vs-Stage4
4.200200E-01
Stage1-vs-Stage2
1.418090E-02
Stage1-vs-Stage3
9.800000E-01
Stage1-vs-Stage4
3.087200E-01
Stage2-vs-Stage3
3.070600E-01
Stage2-vs-Stage4
5.004000E-01
Stage3-vs-Stage4
2.783000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
5.736200E-01
Normal-vs-AfricanAmerican
2.507200E-01
Normal-vs-Asian
4.953200E-01
Caucasian-vs-AfricanAmerican
2.451800E-01
Caucasian-vs-Asian
9.502600E-01
AfricanAmerican-vs-Asian
3.231400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.744400E-01
Normal-vs-Female
4.839600E-01
Male-vs-Female
6.287800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.057400E-01
Normal-vs-Age(41-60Yrs)
3.424400E-01
Normal-vs-Age(61-80Yrs)
6.347400E-01
Normal-vs-Age(81-100Yrs)
9.328000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.302400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.049600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.505600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.905800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.823750E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
4.328000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
9.490600E-01
Normal-vs-Daily Drinker
7.754400E-01
Normal-vs-Weekly Drinker
6.375800E-01
Normal-vs-Occasional Drinker
4.720600E-01
Normal-vs-Social Drinker
3.721200E-01
Non Drinker-vs-Daily Drinker
4.743600E-01
Non Drinker-vs-Weekly Drinker
3.475800E-01
Non Drinker-vs-Occasional Drinker
1.038760E-01
Non Drinker-vs-Social Drinker
6.563800E-02
Daily Drinker-vs-Weekly Drinker
1.543970E-01
Daily Drinker-vs-Occasional Drinker
5.899700E-02
Daily Drinker-vs-Social Drinker
3.828200E-02
Weekly Drinker-vs-Occasional Drinker
2.993000E-01
Weekly Drinker-vs-Social Drinker
1.929650E-01
Occasional Drinker-vs-Social Drinker
7.846800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.330000E-01
Normal-vs-Grade 2
6.208400E-01
Normal-vs-Grade 3
4.773800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.767800E-01
Grade 1-vs-Grade 3
4.997400E-01
Grade 1-vs-Grade 4
7.330000E-01
Grade 2-vs-Grade 3
4.369600E-01
Grade 2-vs-Grade 4
6.208400E-01
Grade 3-vs-Grade 4
4.773800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.388600E-01
Normal-vs-NonDiabetic
5.838600E-01
Diabetic-vs-NonDiabetic
3.948800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.683000E-01
Normal-vs-NoPancreatitis
6.006400E-01
Pancreatitis-vs-NoPancreatitis
2.984400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.998600E-01
Normal-vs-N1
4.650800E-01
N0-vs-N1
3.685600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.428600E-01
Normal-vs-TP53-NonMutant
3.829000E-01
TP53-Mutant-vs-TP53-NonMutant
8.886300E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
